Why Woodford's newest pharma pick is a real pig

Neil Woodford's love of pharmaceutical companies has been well publicised over the past few years, but the income investor has been particularly excited about the prospects of a company using pieces of pig to regrow human tissue.

Woodford, Invesco Perpetual's head of investment, responsible for more than £20bn of assets, has amassed a substantial stake in Tissue Regenix, a York-based medical technology company spun out of Leeds University, according to the Yorkshire Post. The company, which listed on AIM in 2010, participated in a fundraising scheme towards the end of last year, amid dire markets, and managed to raise £25m, largely backed by Woodford, who bought into the company in Q4 last year. The manager now owns 28.6% of the company's listed share capital. His High Income fund alone held 97m shares in the ...